Statins are known to reduce cell proliferation via down-regulation of critical signaling pathways in a few human cancers, including AKT/mTOR, MAPK, JAK2/STAT3, Ras, NF-κB, JUNK and RhoA/ROCK pathways [9, 10, 43, 44]. Here, MTOR is linked to cancer.